未登录

M

Michael Armahizer

university of maryland baltimore

H指数:13

被引数:760

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Status epilepticus in older adults: A critical review

癫痫持续状态在老年患者中的研究：系统综述

IF6.6

2025-05-140

OA

A Propensity Score-Weighted Analysis of Short-Term Corticosteroid Therapy for Refractory Pain Following Spontaneous Subarachnoid Hemorrhage

NEUROCRITICAL CARE

IF3.6

2024-11-190

PRE

Overlapping Physiologic Signs of Sepsis and Paroxysmal Sympathetic Hyperactivity After Traumatic Brain Injury: Exploring A Clinical Conundrum

NEUROCRITICAL CARE

IF3.6

2023-10-261

PRE

Minimizing Shivering During Targeted Normothermia: Comparison Between Novel Transnasal and Surface Temperature-Modulating Devices

NEUROCRITICAL CARE

IF3.6

2023-07-272

OA

Adjunctive virtual reality pain relief after traumatic injury: a proof-of-concept within-person randomized trial

创伤性损伤后的辅助虚拟现实疼痛缓解: 一项概念验证的人体内随机试验

IF5.5

2023-04-195

PRE

Development and Use of an Ex-Vivo In-Vivo Correlation to Predict Antiepileptic Drug Clearance in Patients Undergoing Continuous Renal Replacement Therapy

开发和使用离体体内相关性来预测连续肾脏替代治疗患者的抗癫痫药物清除率

PHARMACEUTICAL RESEARCH

IF4.3

2022-05-133

PRE

Pain Trajectories Following Subarachnoid Hemorrhage are Associated with Continued Opioid Use at Outpatient Follow-Up (Jun, 10.1007/s12028-021-01282-5, 2021)

NEUROCRITICAL CARE

IF3.6

2021-10-180

OAAI

Pain Trajectories Following Subarachnoid Hemorrhage are Associated with Continued Opioid Use at Outpatient Follow-up

NEUROCRITICAL CARE

IF3.6

2021-06-0913

OAAI

Evidence for Andexanet Alpha in Reversing Intracerebral Hemorrhage due to Factor Xa Inhibitors?

IF8.9

2021-06-013

OA

Association of Refractory Pain in the Acute Phase After Subarachnoid Hemorrhage With Continued Outpatient Opioid Use

IF8.5

2021-05-1111

OA

A prospective, real-world, clinical pharmacokinetic study to inform lacosamide dosing in critically ill patients undergoing continuous venovenous haemofiltration (PADRE-02)

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2021-05-053

OAAI

Admission Features Associated With Paroxysmal Sympathetic Hyperactivity After Traumatic Brain Injury: A Case-Control Study

CRITICAL CARE MEDICINE

IF6

2021-04-299

PRE

A qualitative assessment of the diagnosis and management of ventilator-associated pneumonia among critical care clinicians exploring opportunities for diagnostic stewardship

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

IF3

2021-04-1611

PREAI

DEXmedetomidine compared to PROpofol in NEurocritical Care [DEXPRONE]: A multicenter retrospective evaluation of clinical utility and safety

JOURNAL OF CRITICAL CARE

IF2.9

2020-12-017

PREAI

A Practice-Based, Clinical Pharmacokinetic Study to Inform Levetiracetam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration (PADRE-01)

CTS-CLINICAL AND TRANSLATIONAL SCIENCE

IF2.8

2020-04-0311

OAAI

Collaborative Management Strategies for Drug Shortages in Neurocritical Care

NEUROCRITICAL CARE

IF3.6

2019-05-109

OAAI

DEXMEDETOMIDINE VERSUS PROPOFOL IN NEUROCRITICAL CARE: AN EVALUATION OF CLINICAL UTILITY AND SAFETY

CRITICAL CARE MEDICINE

IF6

2018-01-010

PREAI

Corrected QT interval for possible drug-drug interactions in the intensive care unit

JOURNAL OF CRITICAL CARE

IF2.9

2013-12-010

PREAI

Drug-drug interactions contributing to QT prolongation in cardiac intensive care units

JOURNAL OF CRITICAL CARE

IF2.9

2013-06-0159

PREAI

QT prolongation in the intensive care unit: commonly used medications and the impact of drug-drug interactions

EXPERT OPINION ON DRUG SAFETY

IF3.1

2010-04-0922

PREAI